Q&A With Robert Giugliano From Brigham and Women's: PCSK9 Inhibitors Provide Hope for Cardiac Patients
AUGUST 29, 2015
It was less than two decades ago that researchers uncovered the role of PCSK9 in a person's body. In just the past few months two new medications have been developed that could go a long way in helping win the fight against bad cholesterol.
Robert Giugliano, MD, from Brigham and Women's Hospital discussed the early stages of the medication and what it can mean for treatment of patients going forward during the European Society of Cardiology's annual meeting in London.